Abstract
m-Chlorophenylpiperazine (MCPP), a direct 5HT receptor agonist, was administered orally to 20 normal subjects in two doses (0.25 and 0.5 mg/kg) in a placebo-controlled design. Behavioral responses; ACTH, cortisol, prolactin and MCPP blood level; temperature and pulse rate were measured over a 210-min period after administration of tablets. Non-linear dose-response relationships between MCPP and ACTH, cortisol and prolactin response were found. On the higher dose, a significant increase in the number of physical symptoms was also noted and three subjects (15%) had a panic attack, while one subject (5%) had a panic attack on the lower dose. No effects on other behavioral variables, pulse rate and temperature were found using either dose. These findings attest to the usefulness of MCPP as a challenge agent to assess 5HT receptor hypersensitivity when given at a low oral dose (i.e. around 0.25 mg/kg), and to assess 5HT receptor hyposensitivity when given at higher oral doses (i.e. around 0.5 mg/kg).
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aloi JA, Insel TR, Mueller EA, Murphy DL (1984) Neuroendocrine and behavioral effects of MCPP in Rhesus monkeys. Life Sci 34:1325–1331
Aulakh CS, Cohen RM, Hill JL, Murphy DL, Zohar J (1987) Long-term imipramine treatment enhances locomotor and food intake suppressant effects ofm-chlorophenylpiperazine in rats. Br J Pharmacol 91:747–752
Aulakh CS, Wozniak KM, Haas M, Hill JL, Zohar J, Murphy DL (1988) Food intake, neuroendocrine and temperature effects of 8-OHDPAT in the rat. Eur J Pharmacol 146:253–259
Caccia S, Ballabio M, Samanin R, Zanini MG, Garattini S (1981) MCPP, a central 5HT agonist, is a metabolite of Trazodone. J Pharm Pharmacol 33:477–478
Charney DS, Woods SW, Goodman WK, Heninger GR (1987) Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects. Psychopharmacology 92:14–24
Charney DS, Goodman WK, Price LH, Woods SW, Rasmussen SA, Heninger GR (1988) Serotonin function in obsessive-compulsive disorder: a comparison of the effects of tryptophan andm-chlorophenylpiperazine in patients and healthy subjects. Arch Gen Psychiatry 45:177–185
Chrousos G, Schulte HM, Oldfield EH, Gold PhW, Cutler GB, Loriaix DL (1984) The corticotropin-releasing factor stimulation test. N Engl J Med 310:622–626
Conn PJ, Sanders-Bush E (1987) Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic (5HT2 and 5HT1c) receptors. J Pharmacol Exp Ther 242:552–557
Cunningham KA, Appel JB (1986) Possible 5-hydroxytryptaminel receptor involvement in the stimulus properties of 1-(m-trifluoromethylphenyl) piperazine. J Pharmacol Exp Ther 237:369–377
Endicott F, Spitzer RL (1978) A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 35:837–844
Fuller RW, Snoddy HD, Mason NR, Owen JE (1981) Disposition and pharmacological effects of MCPP. Neuropharmacology 20:155–162
Hamik A, Peroutka SJ (1989) 1-(m-Chlorophenyl)piperazine (mCPP) interactions with neurotransmitter receptors in the human brain. Biol Psychiatry 25:569–575
Heninger GR, Krystal JH, Smith A (1988) Effects of D1 and D2 receptor antagonists and 5HT receptor agonists and antagonists on neuroendocrine function in rhesus monkeys. Abstr Soc Neurosci 324:7
Hoyer D (1988) Functional correlates of serotonin 5HT1 recognition sites. J Recept Res 8:59–81
Hoyer D, Pazos A, Probst A, Palacios JM (1986) Serotonin receptors in the human brain. I. Characterization and autoradiographic localization of 5-HT1A recognition sites. Apparent absence of 5-HT1B recognition sites. Brain Res 376:85–96
Invernizzi R, Cotecchia S, DeBlaise A (1981) Effects of MCPP on receptor binding and brain metabolism of monoamines in rats. Neurochem Int 3:239–244
Kahn RS, Asnis GM, Wetzler S, van Praag HM (1988) Neuroendocrine evidence for serotonin receptor supersensitivity in patients with panic disorder. Psychopharmacology 96:360–364
Kennet GA, Curzon G (1988) Evidence that hypophagia induced by mCPP and TFMPP requires 5HT1c and 5HT1b receptors; hypophagia induced by RU 24969 requires only 5HT1b receptors. Psychopharmacology 96:93–100
Kilpatrick GJ, Jones BJ, Tyers MB (1987) Identification and distribution of 5HT3 receptors in rat brain using radioligand binding. Nature 330:746–748
McNair DM, Lorr M, Droppelman LF (1971) Manual for the Profile of Mood States, Educational and Industrial testing Service, San Diego, California
Mueller EA, Sunderland T, Murphy DL (1985) Neuroendocrine effects ofm-CPP, a serotonin agonist, in humans. J Clin Endocrinol Metab 61:1179–1184
Mueller EA, Murphy DL, Sunderland T (1986) Further studies of the putative serotonin agonist,m-chlorophenylpiperazine evidence for a serotonin receptor mediated mechanism of action in humans. Psychopharmacology 89:388–391
Munaro NI (1978) The effects of ovarian steroids on hypothalamic 5-hydroxytryptamine neuronal activity. Neuroendocrinology 26:270–276
Pettibone DJ, Williams M (1984) Serotonin-releasing effects of substituted piperazines in vitro. Biochem Pharmacol 33:1531–1535
Quattrone, G Schettini G, Annunziato L, DiRenzo G (1981) Pharmacological evidence of supersensitivity of central serotonergic receptors involved in the control of prolactin secretion. Eur J Pharmacol 76:9–13
Samanin R, Mennini T, Ferraris A, Bendotti C, Borsini F (1980) Hyper and hyposensitivity of central serotonin receptor: [3H]serotonin binding and functional studies in the rat. Brain Res 189:449–457
Smith TM, Suckow RF (1985) Trazodone andm-chlorophenylpiperazine. Concentration in brain and receptor activity in regions in the brain associated with anxiety. Neuropharmacology 24:1067–1071
Spitzer RL, Endicott J, Robins E (1978) Research Diagnostic Criteria: rationale and reliability. Arch Gen Psychiatry 35:773–782
Zohar J, Mueller EA, Insel TR, Zohar-Kadouch RC, Murphy DL (1987) Serotonergic responsivity in obsessive compulsive disorder: comparison of patients and healthy controls. Arch Gen Psychiatry 44:946–951
Zohar J, Insel TR, Zohar-Kadouch RC, Hill JL, Murphy DL (1988) Serotonergic responsivity in obsessive compulsive disorder: effects of chronic clomipramine treatment. Arch Gen Psychiatry 45:167–172
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kahn, R.S., Wetzler, S., Asnis, G.M. et al. Effects ofm-chlorophenylpiperazine in normal subjects: a dose-response study. Psychopharmacology 100, 339–344 (1990). https://doi.org/10.1007/BF02244603
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02244603